Lilly Looks To Tackle High Lipoprotein(a) Via Gene Editing With Verve

 
• By Joseph Haas
  
Gene editing
Lilly is teaming with Verve in cardiovascular gene-editing therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business